Aktiespot

The Oncology Institute, Inc. Aktie

TOI

After-hours
$4.2300-0.3600 (-7.84%)
Post-Market:$4.2410+0.01 (+0.26%)
Chart wird geladen...
The Oncology Institute, Inc. Logo

The Oncology Institute, Inc.

Eröffnung4.5500
Hoch4.5600
Tief4.2200
Volumen1.34M
P/EN/A
Marktkapitalisierung422.93M
52-Wochen-Hoch4.8950
52-Wochen-Tief2.0150
Durchschn. Volumen1.86M
DividendeN/A
Beta0.36
EPS-0.3500

Über The Oncology Institute, Inc. Aktie

The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Unternehmensinformationen

Börse: NasdaqCM (NCM)
Sektor: Sundhed
Branche: Sundheds- og plejefaciliteter
Adresse:
18000 Studebaker Road
90703 Cerritos, United States
Telefon: + 562 735 3226

Analystenempfehlungen

Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.

Niedrigstes Kursziel
5.00
18.2%
Durchschnittliches Kursziel
7.00
65.5%
Median Kursziel
7.50
77.3%
Höchstes Kursziel
8.00
89.1%

Andere sehen auch: